Co-Authors
This is a "connection" page, showing publications co-authored by Yeonjae Kim and Jae-Phil Choi.
Connection Strength
0.274
-
Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability. Clin Infect Dis. 2021 08 02; 73(3):e550-e558.
Score: 0.060
-
Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study. Clin Microbiol Infect. 2022 Feb; 28(2):292-296.
Score: 0.059
-
Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. J Korean Med Sci. 2020 Apr 06; 35(13):e142.
Score: 0.055
-
Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015. Emerg Infect Dis. 2019 06; 25(6):1161-1168.
Score: 0.052
-
Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome. J Korean Med Sci. 2018 Jun 11; 33(24):e169.
Score: 0.048